 this is a follow - up to the question we asked on the last call. 
 we want to know what you think about the prospects for the atopic derm market with the launch of atogepant in the second half of the year and the launch of atogepant in psoriasis in the second half of the year. 
 we also want to know what you think about the potential for the prophylaxis market with the launch of atogepants in the second half of the year and the potential for the launch of atogepants in psoriasis in the third quarter of the year. 
 we want to know what your expectations are for the launch of atogepants and the launch of atogepants in atopic dermatitis in the second half of the year.    
 # 1_#1 _ # 1_#1 _ =    # 1 1.25 in.125 in.25 in    # 1#2#3#4#1 * # 2 *, # 3 ( # 4 ) # 1#2#3#4#5#6#7#8 * # 1 *, # 3 (